Protecting IP for Protein Therapeutics and Diagnostics
|Event Date/Time: Jan 11, 2009||End Date/Time: Jan 11, 2009|
New rulings continue to emerge from the Supreme Court of the United States that directly impact the ways in which groups and individuals protect their Intellectual
Property (IP) in the area of protein therapeutics and diagnostics.
Topics to be Covered:
Implications of new supreme court rulings
Strategies for protecting IP
Building on existing IP
Thomas J. Kowalski, Partner, Frommer Lawrence & Haug LLP
John Iwanicki, Senior Partner, Banner & Witcoff Ltd.